Stock Alert – Positive phase 3

Share this news with your friends

ImmunoGen: Bold Move To Position A Comeback
Seeking Alpha
As having strong intellectual property protection is paramount to a good
investment, I like the fact that ImmunoGen is deepening its moat. … I look
forward to continuing to work with ImmunoGen to analyze the Phase 3 data and

Sanofi (SNY) Stock Price Declined While Amg National Trust Bank Boosted Its
Position; Retrophin …
The InvestReporter
… SA: New England Journal of Medicine Publishes Two Positive Phase 3
Trials Showing Dupixent Improved Moderate-To-Severe Asthma; 24/04/2018 …

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

1 comment

Leave a Reply

Your email address will not be published. Required fields are marked *